Endocrinology, Vol 126, 1593-1598, Copyright © 1990 by Endocrine Society

ARTICLES

Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion

JL Leahy and KM Vandekerkhove
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215.

Insulin-like growth factors I and II (IGF-I and IGF-II) are thought to primarily regulate the growth and development of a number of tissues. However, it has recently been observed that when IGF-I is infused into man and animals, plasma insulin levels fall, raising the possibility that IGF-I may also be an inhibitor of insulin secretion. This study used the in vitro perfused rat pancreas and recombinant human IGF-I and IGF-II to determine if either of these peptides affected insulin and/or glucagon secretion from normal rats. IGF-I given with 7.8 mM glucose suppressed insulin secretion by as much as 65%, with the half-maximal effect occurring at less than 10 ng/ml. Glucose-induced insulin secretion (7.8 mM glucose) and arginine-induced insulin secretion (10 mM arginine plus 7.8 mM glucose) were inhibited equally (40%) by 2 ng/ml IGF-I. Insulin secretion returned to normal within minutes of stopping IGF-I. IGF-II (200 ng/ml) also suppressed insulin release, but the effect was less pronounced than for IGF-I and was present at 16.7 mM glucose, but not at 7.8 mM glucose. In contrast to the effects on insulin release, neither peptide altered glucagon secretion. We conclude from these results that 1) IGF-I at physiological concentrations is a potent inhibitor of both glucose- and arginine- induced insulin secretion; 2) the magnitude of the inhibition depends on the background glucose concentration; and 3) the inhibition fully reverses when IGF-I is stopped. These results support an in vivo effect of IGF-I to modulate insulin output.

This article has been cited by other articles:

				K. Robertson, Y. Lu, K. De Jesus, B. Li, Q. Su, P. K. Lund, and J.-L. Liu A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E928 - E938. [Abstract] [Full Text] [PDF]

				Y. Ning, A. G. P. Schuller, S. Bradshaw, P. Rotwein, T. Ludwig, J. Frystyk, and J. E. Pintar Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5 Mol. Endocrinol., September 1, 2006; 20(9): 2173 - 2186. [Abstract] [Full Text] [PDF]

				V. Leray, B. Siliart, H. Dumon, L. Martin, R. Sergheraert, V. Biourge, and P. Nguyen Protein Intake Does Not Affect Insulin Sensitivity in Normal Weight Cats J. Nutr., July 1, 2006; 136(7): 2028S - 2030S. [Full Text] [PDF]

				P. G Voorhoeve, E. F C van Rossum, S. J te Velde, J. W Koper, H. C G Kemper, S. W J Lamberts, and H. A D.-v. de Waal Association between an IGF-I gene polymorphism and body fatness: differences between generations. Eur. J. Endocrinol., March 1, 2006; 154(3): 379 - 388. [Abstract] [Full Text] [PDF]

				Y. Lu, P. L. Herrera, Y. Guo, D. Sun, Z. Tang, D. LeRoith, and J.-L. Liu Pancreatic-Specific Inactivation of IGF-I Gene Causes Enlarged Pancreatic Islets and Significant Resistance to Diabetes Diabetes, December 1, 2004; 53(12): 3131 - 3141. [Abstract] [Full Text] [PDF]

				G. Blanchard, P. Nguyen, C. Gayet, I. Leriche, B. Siliart, and B.-M. Paragon Rapid Weight Loss with a High-Protein Low-Energy Diet Allows the Recovery of Ideal Body Composition and Insulin Sensitivity in Obese Dogs J. Nutr., August 1, 2004; 134(8): 2148S - 2150S. [Full Text] [PDF]

				D. Accili Lilly Lecture 2003: The Struggle for Mastery in Insulin Action: From Triumvirate to Republic Diabetes, July 1, 2004; 53(7): 1633 - 1642. [Abstract] [Full Text] [PDF]

				A. NANDI, Y. KITAMURA, C. R. KAHN, and D. ACCILI Mouse Models of Insulin Resistance Physiol Rev, April 1, 2004; 84(2): 623 - 647. [Abstract] [Full Text] [PDF]

				H. Okamoto and D. Accili In Vivo Mutagenesis of the Insulin Receptor J. Biol. Chem., August 1, 2003; 278(31): 28359 - 28362. [Abstract] [Full Text] [PDF]

				W. S. Zawalich and K. C. Zawalich Effects of Glucose, Exogenous Insulin, and Carbachol on C-peptide and Insulin Secretion from Isolated Perifused Rat Islets J. Biol. Chem., July 12, 2002; 277(29): 26233 - 26237. [Abstract] [Full Text] [PDF]

				M. L. Hribal, F. Oriente, and D. Accili Mouse models of insulin resistance Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E977 - E981. [Abstract] [Full Text] [PDF]

				G. A. Lincoln, S. M. Rhind, S. Pompolo, and I. J. Clarke Hypothalamic control of photoperiod-induced cycles in food intake, body weight, and metabolic hormones in rams Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R76 - R90. [Abstract] [Full Text] [PDF]

				S. Yakar, J.-L. Liu, A. M. Fernandez, Y. Wu, A. V. Schally, J. Frystyk, S. D. Chernausek, W. Mejia, and D. Le Roith Liver-Specific igf-1 Gene Deletion Leads to Muscle Insulin Insensitivity Diabetes, May 1, 2001; 50(5): 1110 - 1118. [Abstract] [Full Text]

				F. Frick, J. Oscarsson, K. Vikman-Adolfsson, M. Ottosson, N. Yoshida, and S. Eden Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E729 - E737. [Abstract] [Full Text] [PDF]

				L. E. Levitt Katz, R. J. Ferry Jr., C. A. Stanley, P. F. Collett-Solberg, L. Baker, and P. Cohen Suppression of Insulin Oversecretion by Subcutaneous Recombinant Human Insulin-Like Growth Factor I in Children with Congenital Hyperinsulinism Due to Defective {beta}-Cell Sulfonylurea Receptor J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3117 - 3124. [Abstract] [Full Text]

				L. Carlsson, I. Nilsson, and J. Oscarsson Hormonal Regulation of Liver Fatty Acid-Binding Protein in Vivo and in Vitro: Effects of Growth Hormone and Insulin Endocrinology, June 1, 1998; 139(6): 2699 - 2709. [Abstract] [Full Text] [PDF]

				M. Reinecke, A. Schmid, R. Ermatinger, and D. Loffing-Cueni Insulin-Like Growth Factor I in the Teleost Oreochromis mossambicus, the Tilapia: Gene Sequence, Tissue Expression, and Cellular Localization Endocrinology, September 1, 1997; 138(9): 3613 - 3619. [Abstract] [Full Text] [PDF]

				Q. Zhang, M. Tally, O. Larsson, R. T. Kennedy, L. Huang, K. Hall, and P.-O. Berggren Insulin-like growth factor II signaling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells PNAS, June 10, 1997; 94(12): 6232 - 6237. [Abstract] [Full Text] [PDF]

				D. L. Mortensen, W. B. Won, J. Siu, D. Reifsnyder, M. Gironella, T. Etcheverry, and R. G. Clark Insulin-Like Growth Factor Binding Protein-1 Induces Insulin Release in the Rat Endocrinology, May 1, 1997; 138(5): 2073 - 2080. [Abstract] [Full Text] [PDF]

				H. Olivecrona, A. G. Johansson, E. Lindh, S. Ljunghall, L. Berglund, and B. Angelin Hormonal Regulation of Serum Lipoprotein(a) Levels : Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 847 - 849. [Abstract] [Full Text]